Triple
T916702
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Granta Park |
E19787
|
entity |
| Predicate | hasTenant |
P3277
|
FINISHED |
| Object |
Heptares Therapeutics
Heptares Therapeutics is a biopharmaceutical company specializing in the discovery and development of medicines targeting G protein-coupled receptors (GPCRs) using its proprietary structure-based drug design technologies.
|
E108401
|
NE FINISHED |
Provenance (5 batches)
| Stage | Batch ID | Job type | Status |
|---|---|---|---|
| creating | batch_69a4939f91a08190ba68c2c81eab90fe |
elicitation | completed |
| NER | batch_69a4b2f8e26c81908b768d3e9e67689d |
ner | completed |
| NED1 | batch_69a7cf6062e48190ad7efca6da7d0445 |
ned_source_triple | completed |
| NED2 | batch_69a7d05886c081909e6453d766540720 |
ned_description | completed |
| NEDg | batch_69a7cfd126f48190bff81a9c2d3781f0 |
nedg | completed |
Created at: March 1, 2026, 7:39 p.m.